People ageing with HIV face crucial challenges that can compromise their long-term health,
one of which is stigma. HIV-related stigma can interact with other coexistent inequities to …

The early period of infection with human immunodeficiency virus (HIV) has been associated
with higher infectiousness and, consequently, with more transmission events. Over the last …

ABSTRACT A major barrier to HIV-1 cure is caused by the pool of latently infected CD4 T-
cells that persist under combination antiretroviral therapy (cART). This latent reservoir is …

Introduction Dolutegravir (DTG)-based regimen was included in the expanded formulary of
China's National Free Antiretroviral Treatment Program at the end of 2021. Yet high price of …

Background and objective The life expectancy of people living with HIV (PLWHIV) has
significantly improved in recent decades, mostly due to antiretroviral (ARV) therapy. Aging …

Background In the “treat all” era, there are few data on the nature of HIV clinical progression
in middle-income countries. The aim of the current study was to prospectively analyze the …

ABSTRACT BACKGROUND Tenofovir is one of the antiretroviral (ARV) drugs used as a first-
line regimen known to suppress HIV viral load successfully. However, its clinical application …

Little is known about the coping strategies used among people with HIV (PWH), especially in
sub-Saharan Africa, and the extent to which adaptive or maladaptive coping strategies are …

Background The increased survival provided by the access, development, and evolution of
antiretroviral drugs (ARV) greatly increased the life expectancy of people living with HIV …

Purpose Increase in life expectancy of PLHIV has brought new challenges especially for
young Malay Muslim men who have sex with men (MSM) in Malaysia. This country has …